Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
How to drastically slash your odds of getting Alzheimer's
Alzheimer's affects the lives of millions of people worldwide, but scientists are now starting to un2024-05-08Super Tuesday: What is it and why is it so important?
By Jude SheerinRepublican front-runner Donald Trump will be trying to knock his last remaining rival2024-05-08Ministry of Health proposes 134 job losses
Photo: RNZ / Dom Thomas2024-05-08Super Tuesday: What is it and why is it so important?
By Jude SheerinRepublican front-runner Donald Trump will be trying to knock his last remaining rival2024-05-08St. Louis Blues remove interim tag and name Drew Bannister full
Drew Bannister is returning as coach of the St. Louis Blues after getting the interim tag removed fr2024-05-08- There's growing fears amongst royal fans and experts alike that King Charles' idea of a slimmed-down2024-05-08
atest comment